Krystal Biotech, Inc. (KRYS)
299.45
-4.78
(-1.57%)
USD |
NASDAQ |
May 22, 16:00
299.00
-0.45
(-0.15%)
Pre-Market: 20:00
Krystal Biotech Market Cap : 8.828B for May 22, 2026
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| TG Therapeutics, Inc. | 5.950B |
| Marker Therapeutics, Inc. | 23.34M |
| Moderna, Inc. | 18.60B |
| Catalyst Pharmaceuticals, Inc. | 3.826B |
| Ocugen, Inc. | 453.62M |
Market Cap Related Metrics
| PE Ratio | 40.03 |
| PS Ratio | 21.59 |
| PEG Ratio | 0.4992 |
| Price to Book Value | 6.914 |
| Price to Free Cash Flow | 37.95 |
| Price | 299.45 |
| Earnings Yield | 2.50% |
| PEGY Ratio | 0.4992 |
| Operating PE Ratio | 50.43 |
| Normalized PE Ratio | 40.03 |